REG - BATM Advanced Comm - Result of AGM and Director Appointment

Batm Advanced CommunicationsAnnouncement

19/12/2024 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241219:nRSS8165Qa&default-theme=true

RNS Number : 8165Q  BATM Advanced Communications Ld  19 December 2024

LEI: 213800FLQUB9J289RU66

19 December 2024

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Result of AGM and Director Appointment

 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for
networking solutions and medical laboratory systems, announces that at its
Annual General Meeting ("AGM" or the "Meeting"), held earlier today, all
resolutions were duly passed, including the resolution appointing Dr. Shmuel
(Muli) Ben Zvi as a Non-executive Director of the Group with effect from the
conclusion of the Meeting.

 

Details of the voting results, which should be read alongside the Notice of
AGM, are below:

 

 Resolution  Votes for*                       Votes against                    Votes withheld  Total votes cast
             No. of votes  % of votes cast**  No. of votes  % of votes cast**  No. of votes
 1           302,686,902   99.99              37,322        0.01               119,927         302,844,151
 2           289,249,227   95.54              13,489,997    4.46               104,927         302,844,151
 3           290,229,434   99.98              67,322        0.02               12,547,395      302,844,151
 4           189,028,376   91.79              16,916,348    8.21               104,927         206,049,651
 5           298,028,865   98.44              4,710,359     1.56               104,927         302,844,151
 6           298,028,865   98.44              4,710,359     1.56               104,927         302,844,151
 7           302,619,454   99.99              44,770        0.01               179,927         302,844,151
 8           302,219,045   99.85              445,179       0.15               179,927         302,844,151
 9           298,368,344   98.56              4,370,880     1.44               104,927         302,844,151
 10          201,573,844   66.60              101,090,380   33.40              179,927         302,844,151
 11          185,567,384   91.49              17,255,952    8.51               3,226,315       206,049,651
 12          302,587,954   99.94              167,895       0.06               88,302          302,844,151
 13          289,994,081   95.77              12,821,768    4.23               28,302          302,844,151

* Includes discretionary votes

**Excludes withheld votes

 

The Board is pleased that all resolutions were passed by the requisite
majority of the shareholders who voted, but notes that over 20% of votes cast
were against the Board's recommendation in respect of resolution 10. The Board
will engage with shareholders in respect of this resolution to ensure their
views are understood. In accordance with provision 4 of the UK Corporate
Governance Code, the Board will provide an update on this engagement within
six months of the AGM, as well as a final summary in the Group's annual
report.

 

Other than the below, there are no other required disclosures pursuant
to UK Listing Rule 6.4.8 in relation to Dr. Ben Zvi:

 

 Current directorships held in public companies  Directorships in public companies held within the past five years
 Protalix Biotherapeutics Inc                    Bank Leumi Le Israel BM
                                                 Sol-Gel Technologies Ltd
                                                 VBL Therapeutics Ltd

 

In accordance with UK Listing Rule 6.4.2, a copy of the resolutions, other
than resolutions concerning ordinary business, has been submitted to the
National Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

 

Enquiries

 

 BATM Advanced Communications
 Moti Nagar, Chief Executive Officer                            +972 9866 2525
 Ran Noy, Chief Financial Officer

 Shore Capital
 Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)  +44 20 7408 4050

 Gracechurch Group
 Harry Chathli, Claire Norbury                                  +44 20 4582 3500

 

Forward-looking statements

 

This document contains forward-looking statements. Those statements reflect
the current opinions, evaluations and estimations of the Group's management,
and are based on the current data regarding the Group's business as is
detailed in this document and in the Group's periodical, interim and immediate
reports. The Group does not undertake any obligation or make any
representation that actual results and events will be in line with those
statements, and stresses that they may differ materially from those
statements, due to changes in the Group's business, market, competition,
demand for the Group's products or services, general economic factors or other
factors that can influence the Group's business and results, due to the risk
factors that are detailed in the Group's Annual Report, and due to information
and factors that are currently unknown to the Group's management and that, if
known, would affect the management's opinions, evaluations or estimations. The
Group will report the actual results and events according to its legal,
accounting and regulatory obligations, and does not undertake any other
obligation to report them or their deviations from the forward-looking
statements, or to update any of the forward-looking statements in this
document or to report that it is not valid anymore.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGBUBDDRGBDGSC